-
Which pharmaceutical giant is most willing to invest, and which excels at generating profits?
Krebs Qin
May 27, 2024
The significance of R&D investment in biopharmaceutical companies cannot be overstated.
-
Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies
ACN Newswire
August 02, 2025
Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash.
-
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
Biotech Newswire
July 09, 2024
The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy.
-
InnoCare Appoints Xin Fu as Chief Financial Officer
PharmaSources
December 18, 2023
InnoCare Pharma, announced today that the Company appointed Mr. Xin Fu, who has extensive finance-related experience, as the Chief Financial Officer.
-
4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection
B3C newswire
November 06, 2023
In a significant financial milestone, Xlife Sciences AG invests CHF 23.3 million in 4D Lifetec AG, acquiring a 20% stake in the company.
-
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
PharmaSources.com
May 05, 2022
Avantor announced it will create a new manufacturing and distribution Hub in Singapore.
-
2021 — the year UK biotechs broke investment records
CPhIonline
February 10, 2022
Initial Public Offerings totalled £1,304 million, an increase of 434% from 2020, but more needs to be done to connect the UK's life sciences and finance sectors.
-
Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction
prnasia
August 04, 2021
Coller Capital and Ping An Overseas Holdings together with its subsidiaries, the main offshore investment and asset management platform of Ping An Insurance (Group) Company of China, Ltd., have closed one of the world's largest private credit ...
-
Sanofi invests 50 million euros in Jeito Capital
expresspharma
November 16, 2020
The investment will be deployed by Jeito’s team, in line with its investment criteria, to support French and European healthcare entrepreneurs.
-
Recipharm Invests €2.6M in Kaysersberg Facility
contractpharma
October 16, 2020
The Kaysersberg facility specializes in producing sterile liquids for therapeutic areas including eye care and ear drops.